Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesViemed Healthcare Inc

Viemed Healthcare Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
8.835 USD -0.29 ( 3.23%)
Last update at 2026-11-09T17:53:00Z
VOLUME
120349
Market Cap
333.27M
P/E
25.00

Momentum Score

…

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
8.71
Low
9.35
High
52 Week Price Range
6.05
Low
12.61
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
9.13
Dividend Yield
-
Revenue TTM
301.61M
Revenue Per Share
7.87
Gross Profit TTM
173.32M
Debt / Equity
0.11
ROE
10.45%
Net Debt
2.45M
ROCE
13.20%
Diluted EPS TTM
0.35

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 21.77M 16.17M 14.39M 8.99M 12.50M
Minority interest -0.44M -0.14M 0.00M - -
Net income 14.93M 11.27M 10.24M 6.22M 9.13M
Selling general administrative 130.50M 112.48M 93.73M 73.36M 60.04M
Selling and marketing expenses - - 0.54M 5.20M -
Gross profit 155.46M 133.20M 112.78M 84.68M 73.41M
Reconciled depreciation 28.61M 25.37M 20.32M 15.63M 11.31M
Ebit 22.95M 16.95M 14.81M 8.25M 11.58M
Ebitda 51.56M 42.31M 36.68M 24.57M 23.79M
Depreciation and amortization 28.61M 25.37M 21.86M 16.32M 12.21M
Non operating income net other - - - 0.94M 1.24M
Operating income 20.71M 17.90M 14.33M 8.25M 11.58M
Other operating expenses 249.57M 206.36M 168.68M 130.23M 105.03M
Interest expense 1.18M 0.78M 0.42M 0.20M 0.32M
Tax provision 6.39M 4.76M 3.69M 2.77M 3.38M
Net interest income -1.18M -0.78M -0.20M -0.20M -0.32M
Income tax expense 6.39M 4.76M 4.15M 2.77M 3.38M
Total revenue 270.28M 224.26M 183.01M 138.83M 117.06M
Total operating expenses 134.75M 115.30M 98.45M 76.08M 61.38M
Cost of revenue 114.82M 91.05M 70.22M 54.15M 43.65M
Total other income expense net 1.06M -1.73M 0.06M 0.74M 0.92M
Net income from continuing ops 15.38M 11.41M 9.20M 6.22M 9.13M
Net income applicable to common shares - - - 6.22M 9.13M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 214.94M 177.07M 154.10M 117.04M 117.96M
Intangible assets 1.28M 0.85M 0.57M - -
Other current assets 4.36M 6.11M 2.44M 3.85M 1.73M
Total liab 71.42M 43.77M 40.79M 19.95M 23.14M
Total stockholder equity 141.54M 131.39M 113.31M 97.09M 94.82M
Other current liab 18.91M 16.14M 19.63M 11.09M 8.88M
Common stock 16.91M 23.36M 18.61M 15.12M 14.01M
Capital stock 16.91M 23.36M 18.70M 15.12M 14.01M
Retained earnings 102.89M 89.69M 79.09M 69.85M 73.33M
Other liab - - - 0.89M 0.76M
Good will 58.94M 32.99M 29.61M - -
Other assets - - 0.00M 4.71M 5.65M
Cash 13.50M 17.54M 12.77M 16.91M 28.41M
Total current liabilities 41.06M 37.33M 31.96M 18.86M 17.81M
Current deferred revenue 7.52M 6.69M 6.18M 4.62M 3.75M
Net debt 2.45M -10.67M -2.50M -16.22M -21.89M
Short term debt 2.29M 1.27M 2.00M 0.49M 1.94M
Short long term debt 1.09M 0.41M 1.07M - 1.48M
Short long term debt total 15.95M 6.87M 10.27M 0.69M 6.52M
Other stockholder equity 21.74M 18.34M 15.62M 12.12M 7.75M
Property plant equipment - - - 68.44M 62.85M
Total current assets 48.49M 52.88M 38.17M 39.74M 47.31M
Long term investments 2.79M 2.79M 3.90M 2.15M 2.16M
Net tangible assets - - - 97.09M 94.82M
Short term investments - - - -2.00M -
Net receivables 25.59M 24.91M 18.36M 15.40M 14.72M
Long term debt 11.29M 3.59M 6.00M - 4.31M
Inventory 5.05M 4.32M 4.60M 3.57M 2.46M
Accounts payable 12.33M 9.34M 4.16M 2.65M 3.24M
Accumulated other comprehensive income - - - -0.28M -0.28M
Common stock total equity - - - 15.12M 14.01M
Retained earnings total equity - - - 69.85M 73.33M
Non currrent assets other 15.79M -105.76M 0.73M 1.59M 0.86M
Non current assets total 166.45M 124.19M 115.93M 77.30M 70.65M
Capital lease obligations 3.57M 2.87M 3.25M 0.69M 0.73M
Long term debt total - - - - 4.31M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.00M -30.70M -52.00M -2.00M -0.60M
Change to liabilities - - - 4.10M -6.12M
Total cashflows from investing activities -50.17M -30.70M -52.11M -23.98M -19.75M
Net borrowings 8.22M -3.41M 2.12M -5.80M -1.83M
Total cash from financing activities -5.79M -3.69M 2.83M -15.27M -5.32M
Change to operating activities - - - -0.29M -4.25M
Net income 14.93M 11.41M 10.24M 6.22M 9.13M
Change in cash -4.04M 4.70M -4.08M -11.49M -2.57M
Begin period cash flow 17.54M 12.84M 16.91M 28.41M 30.98M
End period cash flow 13.50M 17.54M 12.84M 16.91M 28.41M
Total cash from operating activities 51.92M 39.09M 45.21M 27.75M 22.49M
Depreciation 28.61M 25.37M 21.86M 15.63M 11.31M
Other cashflows from investing activities 16.15M 9.32M 2.57M 0.92M -0.00M
Dividends paid - - 0.43M - -
Change to inventory 0.06M 0.57M -0.48M 0.30M -0.21M
Change to account receivables 1.16M -6.07M -1.08M -12.57M -7.34M
Sale purchase of stock -13.22M -1.07M -0.59M -9.71M -1.43M
Other cashflows from financing activities -2.16M 0.79M 1.30M 0.28M 0.11M
Change to netincome - - - 16.97M 16.86M
Capital expenditures 39.98M 37.77M 26.09M 22.90M 19.74M
Change receivables - - - -12.57M -7.34M
Cash flows other operating - - - -2.90M -1.12M
Cash and cash equivalents changes - - - -11.49M -2.57M
Change in working capital -2.30M 0.35M 7.78M -10.13M -13.56M
Stock based compensation 9.13M 6.29M 5.85M 5.20M 5.15M
Other non cash items -1.57M -0.49M 0.92M 9.08M 6.58M
Free cash flow 11.93M 1.32M 19.12M 4.85M 2.75M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
VMD
Viemed Healthcare Inc		 -0.29
3.23%		 8.84 25.00 18.28 1.10 2.34 1.12 5.94
ABT
Abbott Laboratories		 0.46
0.42%		 110.39 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 1.75
1.72%		 103.55 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 1.50
0.46%		 327.37 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 0.56
1.12%		 50.41 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Viemed Healthcare Inc

Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

625 East Kaliste Saloom Road, Lafayette, LA, United States, 70508

337 504 3802

https://www.viemed.com

1438

Name Title Year Born
Mr. Casey Hoyt CEO & Director 1977
Mr. Michael B. Moore CRT Pres 1978
Mr. Trae Paul Fitzgerald Chief Financial Officer 1989
Mr. William Todd Zehnder COO & Director 1975
Dr. William Dana Frazier M.D. Chief Medical Officer & Director 1958
Mr. Jeremy Trahan Chief Legal Officer and Exec. VP of Acquisitions & Strategic Transactions NA
Mr. Patrick Eagan Gen. Counsel 1979
Mr. Michael Freeman Chief Bus. Devel. Officer NA
Mr. Robert Grossman LLB Corp. Sec. 1974
Mr. Michael B. Moore CRT President 1977

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

GFR
CAD 10.94
+37.96%
MOON
CAD 4.90
+11.11%
UCU
CAD 2.37
+10.75%
ANRG
CAD 1.90
+10.47%
EPRX
CAD 10.71
+10.30%
DIV
CAD 3.77
-7.37%
CSU
CAD 3281.97
-6.93%
LMN
CAD 26.62
-5.23%
TOI
CAD 99.75
-4.80%
GRZ
CAD 5.05
-4.72%

Equity Sectors*

  • Basic Materials

    +4.21%

  • Communication Services

    -0.63%

  • Consumer Cyclical

    +1.12%

  • Consumer Defensive

    +0.09%

  • Energy

    +1.91%

  • Financial Services

    +1.63%

  • Healthcare

    +1.49%

  • Industrials

    +3.56%

  • Real Estate

    +0.66%

  • Technology

    +1.84%

  • Utilities

    +1.24%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…